Arterial Vascular Engineering AVEI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arterial Vascular Engineering AVEI

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mmeggs who wrote (403)	11/25/1998 12:13:00 PM
From: Dave Chanoux	Read Replies (1) of 410

Regarding the MDT divestiture: As I read it, MDT sold off only the non-coronary stent business. Am I reading something that isn't there? Does MDT have other coronary stent business which is unaffected by this. I also find it odd that a private company is buying it. I am not too confident of my next statement but will make it with that disclaimer: It sounds like a give-away or bailout of losing operation. Private companies (based on my experience, I own one) don't have access to the levels of capital that public ones have. Generally private ones build up with low levels of liquidity to try to become public so as to become liquid. This is going backward for Intravascular Therapeutics unless they were paid to take it away. Pure speculation on my part, make your own conclusions. Regards, happy thanksgiving. Dave Chanoux

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next